Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hospices Civils de Lyon
Age
40–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient aged between 40 and 80 years old,
Patients with diagnosis of T2DM\* or obesity (defined according to World Health Organization as a BMI≥ 30 kg/m2)
Patient with hepatic steatosis determined by conventional abdominal ultrasound as defined by the EASL/EASO/EASD European guidelines.
Patient who agrees to be included in the study and who signs the informed consent form,
Patient affiliated to a healthcare insurance plan.
You may not be if
Evidence of other causes of chronic liver disease:
History of ingestion of medications known to produce steatosis in the previous 6 months.
Evidence of cirrhosis or previously known cirrhosis based on the results from previous liver biopsy or history of portal hypertension presented by ascites, hepatic encephalopathy or varices
Presence of regular and/or excessive use of alcohol (defined as \>30g/day for males and \>15g/day for females) for a period longer than 2 years at any times in the last 10 years
The subject is a pregnant or nursing female
Life expectancy less than 5 years
History of known HIV infection
History of type 1 diabete
BMI ≥ 40 kg/m2
Mentally unbalanced patients, under supervision or guardianship,
Patient deprived of liberty,
Patient who does not understand French/ is unable to give consent,
Patient already included in a trial who may interfere with the study or in a period of exclusion following participation in a previous study.
Clareo Health | Screening for NAFLD-related Advanced Fibrosis in High Risk Population in Diabetology.
